Advertisement
Screener

DocGo Inc. (DCGO) ROE

DocGo Inc. ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • DocGo Inc. roe for the quarter ending 2026-06-30 was -173.61%, a change of -164.37% year-over-year.
  • DocGo Inc. roe for the quarter ending 2026-03-31 was -152.66%, a change of -149.97% year-over-year.
  • DocGo Inc. roe for the quarter ending 2025-12-31 was -136.35%, a 3375.21% decline year-over-year.
  • DocGo Inc. roe for the quarter ending 2025-09-30 was -22.80%, a 355.65% decline year-over-year.
  • DocGo Inc. roe for fiscal 2025 was -144.91%, a 2384.52% decline from fiscal 2024.
  • DocGo Inc. roe for fiscal 2024 was 6.34%, a 182.24% increase from fiscal 2023.
  • DocGo Inc. roe for fiscal 2023 was 2.25%, a 81.87% decline from fiscal 2022.
  • DocGo Inc. roe for fiscal 2022 was 12.40%, a 18.57% increase from fiscal 2021.
Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2026-06-30-173.61%-$206.69M-$15.82M$119.05M
2026-03-31-152.66%-$201.99M-$14.76M$132.31M
2025-12-31-136.35%-$196.37M-$148.04M$144.01M
2025-09-30-22.80%-$61.67M-$27.77M$270.53M
2025-06-30-9.24%-$27.47M-$11.16M$297.28M
2025-03-31-2.69%-$8.32M-$9.41M$309.34M
2024-12-314.16%$13.36M-$9.89M$320.92M
2024-09-308.92%$29M$5.50M$325.21M
2024-06-309.23%$29.09M$6.53M$315.16M
2024-03-317.89%$24.57M$11.23M$311.32M
2023-12-313.34%$10.05M$7.57M$300.79M
2023-09-303.20%$9.2M$4.76M$287.6M
2023-06-302.52%$7.04M$279.77M
2023-03-316.26%$17.45M-$3.47M$278.68M
2022-12-3111.25%$30.74M$10.99M$273.23M

Annual ROE

DateROENet income 12 monthShareholder equity
2025-12-31-144.91%-$182.4M$125.87M
2024-12-316.34%$19.99M$315.18M
2023-12-312.25%$6.86M$305.17M
2022-12-3112.40%$34.58M$278.93M
2021-12-3110.46%$23.74M$227.06M
2020-12-31-22.11%-$14.8M$66.95M

Similar stocks

Stock NameCountryMarket CapPE Ratio
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86